<article title='Bacterial_vaginosis'><paragraph><template><target>Use dmy dates</target><arg name="date">July 2012</arg></template><template><target>Infobox disease</target><arg name="Name"><space/>Bacterial vaginosis
<space/></arg><arg name="Image"><space/>Vaginose-G15.jpg
<space/></arg><arg name="Caption"><space/>Micrograph of bacterial vaginosis — [[squamous cell|cell]]s of the [[cervix]] covered with rod-shaped bacteria, ''[[Gardnerella vaginalis]]'' (arrows).
<space/></arg><arg name="field"><space/>[[Gynecology]], [[Infectious disease (medical specialty)|infectious disease]]
<space/></arg><arg name="DiseasesDB">
<space/></arg><arg name="ICD10"><space/>{{ICD10|B|96||b|95}}, {{ICD10|N|76||n|70}}
<space/></arg><arg name="ICD9"><space/>{{ICD9|616.1}}
<space/></arg><arg name="ICDO">
<space/></arg><arg name="OMIM">
<space/></arg><arg name="MedlinePlus">
<space/></arg><arg name="eMedicineSubj">
<space/></arg><arg name="eMedicineTopic">
<space/></arg><arg name="MeshID"><space/>D016585
</arg></template></paragraph><preblock><preline><bold>Bacterial vaginosis</bold><space/>(<bold>BV</bold>), also known as<space/><bold>vaginal bacteriosis</bold><space/>or<space/><bold>Gardnerella vaginitis</bold>,<extension extension_name='ref' name="History1997"><template><target>cite book</target><arg name="last1">Borchardt</arg><arg name="first1">Kenneth A.</arg><arg name="title">Sexually transmitted diseases : epidemiology, pathology, diagnosis, and treatment</arg><arg name="date">1997</arg><arg name="publisher">CRC Press</arg><arg name="location">Boca Raton [u.a.]</arg><arg name="isbn">9780849394768</arg><arg name="pages">4</arg><arg name="url">https://books.google.ca/books?id</arg></template></extension><space/>is a<space/><link><target>disease</target></link><space/>of the<space/><link><target>vagina</target></link><space/>caused by excessive<space/><link><target>bacteria</target></link>.<extension extension_name='ref' name="Don2014"></extension><extension extension_name='ref' name="ClarkTal2014"><template><target>cite journal</target><arg name="last1">Clark</arg><arg name="first1">Natalie</arg><arg name="last2">Tal</arg><arg name="first2">Reshef</arg><arg name="last3">Sharma</arg><arg name="first3">Harsha</arg><arg name="last4">Segars</arg><arg name="first4">James</arg><arg name="title">Microbiota and Pelvic Inflammatory Disease</arg><arg name="journal">Seminars in Reproductive Medicine</arg><arg name="volume">32</arg><arg name="issue">01</arg><arg name="year">2014</arg><arg name="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148456/<space/></arg><arg name="pages">043–049</arg><arg name="issn">1526-8004</arg><arg name="doi">10.1055/s-0033-1361822</arg></template></extension><space/>Common symptoms include increased<space/><link><target>vaginal discharge</target></link><space/>that often smells like fish. The discharge is usually white or gray in color.<space/><link><target>Dysuria</target><part>Burning with urination</part></link><space/>may occur.<extension extension_name='ref' name="NIH2013S"></extension><space/>Itching is uncommon.<extension extension_name='ref' name="Don2014"></extension><extension extension_name='ref' name="NIH2013S"></extension><space/>Occasionally there may be no symptoms.<extension extension_name='ref' name="NIH2013S"><template><target>cite web</target><arg name="title">What are the symptoms of bacterial vaginosis?</arg><arg name="url">http://www.nichd.nih.gov/health/topics/bacterialvag/conditioninfo/Pages/symptoms.aspx</arg><arg name="website">http://www.nichd.nih.gov/</arg><arg name="accessdate">3 March 2015</arg><arg name="date">2013-05-21</arg></template></extension><space/>Having BV increases the risk of infection by a number of other<space/><link><target>sexually transmitted infections</target></link><space/>including<space/><link><target>HIV/AIDS</target></link>.<extension extension_name='ref' name="Ken2013"><template><target>cite journal</target><arg name="last1">Kenyon</arg><arg name="first1">C</arg><arg name="last2">Colebunders</arg><arg name="first2">R</arg><arg name="last3">Crucitti</arg><arg name="first3">T</arg><arg name="title">The global epidemiology of bacterial vaginosis: a systematic review.</arg><arg name="journal">American journal of obstetrics and gynecology</arg><arg name="date">December 2013</arg><arg name="volume">209</arg><arg name="issue">6</arg><arg name="pages">505–23</arg><arg name="pmid">23659989</arg><arg name="doi">10.1016/j.ajog.2013.05.006</arg></template></extension><space/>It also increases the risk of<space/><link><target>preterm</target><part>early delivery</part></link><space/>among pregnant women.<extension extension_name='ref' name="Queenan2012"><template><target>cite book</target><arg name="last1">Queena</arg><arg name="first1">John T. .</arg><arg name="last2">Spong</arg><arg name="first2">Catherine Y</arg><arg name="last3">Lockwood</arg><arg name="first3">Charles J., editors</arg><arg name="title">Queenan's management of high-risk pregnancy : an evidence-based approach</arg><arg name="page">262</arg><arg name="date">2012</arg><arg name="publisher">Wiley-Blackwell</arg><arg name="location">Chichester, West Sussex</arg><arg name="isbn">9780470655764</arg><arg name="edition">6th</arg></template></extension><extension extension_name='ref'><template><target>cite web</target><arg name="title">What are the treatments for bacterial vaginosis (BV)?</arg><arg name="url">http://www.nichd.nih.gov/health/topics/bacterialvag/conditioninfo/Pages/treatments.aspx</arg><arg name="website">http://www.nichd.nih.gov/</arg><arg name="accessdate">4 March 2015</arg><arg name="date">2013-07-15</arg></template></extension></preline></preblock><preblock><preline>BV is caused by an imbalance of the naturally occurring bacteria in the vagina.<extension extension_name='ref' name="NIH2013O"></extension><space/>There is a change in the most common type of bacteria and a hundred to thousandfold increase in total numbers of bacteria present.<extension extension_name='ref' name="Don2014"></extension><space/>Risk factors include<space/><link><target>douching</target></link>, new or multiple sex partners,<space/><link><target>antibiotic</target><trail>s</trail></link>, and using an<space/><link><target>intrauterine device</target></link><space/>among others.<extension extension_name='ref' name="NIH2013O"></extension><space/>However, it is not considered a sexually transmitted infection.<extension extension_name='ref' name="cdc.gov"><template><target>cite web</target><arg name="url">http://www.cdc.gov/std/bv/stdfact-bacterial-vaginosis.htm<space/></arg><arg name="title">Bacterial Vaginosis – CDC Fact Sheet<space/></arg><arg name="author"><space/></arg><arg name="date">March 11, 2014<space/></arg><arg name="publisher">[[Centers for Disease Control and Prevention]]<space/></arg><arg name="accessdate">2 Mar 2015</arg></template></extension><space/>Diagnosis is suspected based on the symptoms and may be verified by testing the vaginal discharge and finding a higher than normal vaginal<space/><link><target>pH</target></link><space/>and large numbers of bacteria.<extension extension_name='ref' name="Don2014"></extension><space/>BV is often confused with a<space/><link><target>vaginal yeast infection</target></link><space/>or<space/><link><target>infection with Trichomonas</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Mashburn</arg><arg name="first1">J</arg><arg name="title">Etiology, diagnosis, and management of vaginitis.</arg><arg name="journal">Journal of midwifery & women's health</arg><arg name="date">2006</arg><arg name="volume">51</arg><arg name="issue">6</arg><arg name="pages">423–30</arg><arg name="pmid">17081932</arg><arg name="doi">10.1016/j.jmwh.2006.07.005</arg></template></extension></preline></preblock><preblock><preline>Usually treatment is with an antibiotic, such as<space/><link><target>clindamycin</target></link><space/>or<space/><link><target>metronidazole</target></link>. These medications may also be used in the second or third trimesters of<space/><link><target>pregnancy</target></link>. However, the condition often recurs following treatment.<space/><link><target>Probiotic</target><trail>s</trail></link><space/>may help prevent re-occurrence.<extension extension_name='ref' name="Don2014"><template><target>cite journal</target><arg name="last1">Donders</arg><arg name="first1">GG</arg><arg name="last2">Zodzika</arg><arg name="first2">J</arg><arg name="last3">Rezeberga</arg><arg name="first3">D</arg><arg name="title">Treatment of bacterial vaginosis: what we have and what we miss.</arg><arg name="journal">Expert opinion on pharmacotherapy</arg><arg name="date">April 2014</arg><arg name="volume">15</arg><arg name="issue">5</arg><arg name="pages">645–57</arg><arg name="pmid">24579850</arg><arg name="doi">10.1517/14656566.2014.881800</arg></template></extension><space/>It is unclear if the use of probiotics or antibiotics affects pregnancy outcomes.<extension extension_name='ref' name="Don2014"></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Othman</arg><arg name="first1">M</arg><arg name="last2">Neilson</arg><arg name="first2">JP</arg><arg name="last3">Alfirevic</arg><arg name="first3">Z</arg><arg name="title">Probiotics for preventing preterm labour.</arg><arg name="journal">The Cochrane database of systematic reviews</arg><arg name="date">24 January 2007</arg><arg name="issue">1</arg><arg name="pages">CD005941</arg><arg name="pmid">17253567</arg></template></extension></preline></preblock><preblock><preline>BV is the most common vaginal infection in women of reproductive age.<extension extension_name='ref' name="NIH2013O"><template><target>cite web</target><arg name="title">Bacterial Vaginosis (BV): Condition Information</arg><arg name="url">http://www.nichd.nih.gov/health/topics/bacterialvag/conditioninfo/Pages/default.aspx</arg><arg name="website">http://www.nichd.nih.gov/</arg><arg name="accessdate">3 March 2015</arg><arg name="date">2013-05-21</arg></template></extension><space/>The percentage of women affected at any given time varies between 5% and 70%.<extension extension_name='ref' name="Ken2013"></extension><space/>BV is most common in parts of Africa and least common in Asia and Europe.<extension extension_name='ref' name="Ken2013"></extension><space/>In the United States about 30% of women between the ages of 14 and 49 are affected.<extension extension_name='ref' name="CDC2010Stats"><template><target>cite web</target><arg name="title">Bacterial Vaginosis (BV) Statistics Prevalence</arg><arg name="url">http://www.cdc.gov/std/bv/stats.htm</arg><arg name="website">cdc.gov</arg><arg name="accessdate">3 March 2015</arg><arg name="date">September 14, 2010</arg></template></extension><space/>Rates vary considerably between<space/><link><target>ethnic group</target><trail>s</trail></link><space/>within a country.<extension extension_name='ref' name="Ken2013"></extension><space/>While BV like symptoms have been described for much of recorded history, the first clearly documented case occurred in 1894.<extension extension_name='ref' name="History1997"></extension></preline></preblock><heading level='2'>Signs and symptoms</heading><paragraph>Common symptoms include increased<space/><link><target>vaginal discharge</target></link><space/>that usually smells like fish. The discharge is often white or gray in color. There may be<space/><link><target>Dysuria</target><part>burning with urination</part></link>. Occasionally there may be no symptoms.<extension extension_name='ref' name="NIH2013S"></extension></paragraph><paragraph>The discharge coats the walls of the vagina, and is usually without significant irritation, pain, or<space/><link><target>erythema</target></link><space/>(redness), although mild<space/><link><target>Pruritus</target><part>itching</part></link><space/>can sometimes occur. By contrast, the normal vaginal discharge will vary in consistency and amount throughout the<space/><link><target>menstrual cycle</target></link><space/>and is at its clearest at<space/><link><target>ovulation</target></link>about 2 weeks before the<space/><link><target>menstruation</target><part>period</part></link><space/>starts. Some practitioners claim that BV can be asymptomatic in almost half of affected women,<extension extension_name='ref' name="pmid11120507"><template><target>cite journal</target><arg name="author"><space/>Schwebke JR<space/></arg><arg name="title"><space/>Asymptomatic bacterial vaginosis: response to therapy<space/></arg><arg name="journal"><space/>Am. J. Obstet. Gynecol.<space/></arg><arg name="volume"><space/>183<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>1434–9<space/></arg><arg name="year"><space/>2000<space/></arg><arg name="pmid"><space/>11120507<space/></arg><arg name="doi"><space/>10.1067/mob.2000.107735<space/></arg></template></extension><space/>though others argue that this is often a misdiagnosis.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Forney LJ, Foster JA, Ledger W<space/></arg><arg name="title"><space/>The vaginal flora of healthy women is not always dominated by Lactobacillus species<space/></arg><arg name="journal"><space/>Journal of Infections Diseases<space/></arg><arg name="volume"><space/>194<space/></arg><arg name="issue"><space/>10<space/></arg><arg name="pages"><space/>1468–9<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>17054080<space/></arg><arg name="doi"><space/>10.1086/508497<space/></arg></template></extension></paragraph><heading level='2'>Causes</heading><paragraph><template><target>main</target><arg>List of bacterial vaginosis microbiota</arg></template>Healthy vaginal microbiota consists of species which do not cause symptoms, infections, or negatively affect pregnancy. It is dominated mainly by Lactobacillus species.<extension extension_name='ref' name="PetrovaLievens2015"><template><target>cite journal</target><arg name="last1">Petrova</arg><arg name="first1">Mariya I.</arg><arg name="last2">Lievens</arg><arg name="first2">Elke</arg><arg name="last3">Malik</arg><arg name="first3">Shweta</arg><arg name="last4">Imholz</arg><arg name="first4">Nicole</arg><arg name="last5">Lebeer</arg><arg name="first5">Sarah</arg><arg name="title">Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health</arg><arg name="journal">Frontiers in Physiology</arg><arg name="volume">6</arg><arg name="year">2015</arg><arg name="issn">1664-042X</arg><arg name="doi">10.3389/fphys.2015.00081</arg></template></extension><space/>BV is defined by the disequilibrium in the<space/><link><target>List of microbiota species of the lower reproductive tract of women</target><part>vaginal microbiota</part></link><space/>with decline in the number of<space/><link><target>lactobacilli</target></link>. While the infection involves a number of bacteria, it is believed that most infections start with<space/><link><target>Gardnerella vaginalis</target></link><space/>creating a<space/><link><target>biofilm</target></link><space/>which allows other<space/><link><target>opportunistic infection</target><part>opportunistic bacteria</part></link><space/>to thrive.<extension extension_name='ref' name="ClarkTal2014"></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Patterson</arg><arg name="first1">J. L.</arg><arg name="last2">Stull-Lane</arg><arg name="first2">A.</arg><arg name="last3">Girerd</arg><arg name="first3">P. H.</arg><arg name="last4">Jefferson</arg><arg name="first4">K. K.</arg><arg name="title">Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes</arg><arg name="journal">Microbiology</arg><arg name="date">12 November 2009</arg><arg name="volume">156</arg><arg name="issue">2</arg><arg name="pages">392–399</arg><arg name="doi">10.1099/mic.0.034280-0</arg></template></extension></paragraph><paragraph>One of the main risks for developing BV is<space/><link><target>douching</target></link>, which alters the vaginal flora and predisposes women to developing BV.<extension extension_name='ref' name="Cottrell"><template><target>cite journal</target><arg name="author"><space/>Cottrell BH<space/></arg><arg name="title"><space/>An Updated Review of Evidence to Discourage Douching<space/></arg><arg name="journal"><space/>MCN, the American Journal of Maternal/Child Nursing<space/></arg><arg name="volume"><space/>35<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>102–107; quiz 107–9<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20215951<space/></arg><arg name="pmc"><space/></arg><arg name="doi"><space/>10.1097/NMC.0b013e3181cae9da<space/></arg></template></extension><space/>Douching is strongly discouraged by the<space/><link><target>U.S. Department of Health and Human Services</target></link><space/>and various medical authorities, for this and other reasons.<extension extension_name='ref' name="Cottrell"></extension></paragraph><paragraph>BV is a risk factor for<space/><link><target>pelvic inflammatory disease</target></link>, HIV, sexually transmitted infections (STIs), and reproductive and obstetric disorders or negative outcomes. It is possible for sexually inactive persons to develop bacterial vaginosis.<extension extension_name='ref' name="ClarkTal2014"></extension></paragraph><paragraph>Bacterial vaginosis may sometimes affect women after<space/><link><target>menopause</target></link>. Subclinical iron deficiency may correlate with bacterial vaginosis in early pregnancy.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Verstraelen H, Delanghe J, Roelens K, Blot S, Claeys G, Temmerman M<space/></arg><arg name="title"><space/>Subclinical iron deficiency is a strong predictor of bacterial vaginosis in early pregnancy<space/></arg><arg name="journal"><space/>BMC Infect. Dis.<space/></arg><arg name="volume"><space/>5<space/></arg><arg name="pages"><space/>55<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>16000177<space/></arg><arg name="pmc"><space/>1199597<space/></arg><arg name="doi"><space/>10.1186/1471-2334-5-55<space/></arg><arg name="url"><space/>http://www.biomedcentral.com/1471-2334/5/55<space/></arg><arg name="issue">1</arg></template></extension><space/>A longitudinal study published in February 2006 in the American Journal of Obstetrics and Gynecology showed a link between psychosocial stress and bacterial vaginosis persisted even when other risk factors were taken into account.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Nansel TR, Riggs MA, Yu KF, Andrews WW, Schwebke JR, Klebanoff MA<space/></arg><arg name="title"><space/>The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort<space/></arg><arg name="journal"><space/>Am. J. Obstet. Gynecol.<space/></arg><arg name="volume"><space/>194<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>381–6<space/></arg><arg name="date"><space/>February 2006<space/></arg><arg name="pmid"><space/>16458633<space/></arg><arg name="pmc"><space/>2367104<space/></arg><arg name="doi"><space/>10.1016/j.ajog.2005.07.047<space/></arg><arg name="url"><space/>http://linkinghub.elsevier.com/retrieve/pii/S0002-9378(05)01131-2<space/></arg></template></extension><space/>Exposure to the spermicide<space/><link><target>nonoxynol-9</target></link><space/>does not affect the risk of developing bacterial vaginosis.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Wilkinson</arg><arg name="first1">D</arg><arg name="last2">Ramjee</arg><arg name="first2">G</arg><arg name="last3">Tholandi</arg><arg name="first3">M</arg><arg name="last4">Rutherford</arg><arg name="first4">G</arg><arg name="title">Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men.</arg><arg name="journal">The Cochrane database of systematic reviews</arg><arg name="date">2002</arg><arg name="issue">4</arg><arg name="pages">CD003939</arg><arg name="pmid">12519623</arg></template></extension></paragraph><paragraph>Having a<space/><link><target>Women who have sex with women</target><part>female partner</part></link><space/>increases the risk of BV by 60%. The bacteria associated with BV have been isolated from<space/><link><target>Male reproductive system</target><part>male genitalia</part></link>. BV microbiota have been found in the<space/><link><target>penis</target></link>,<space/><link><target>coronal sulcus</target></link>, and<space/><link><target>male urethra</target></link>, in the male partners of infected females. Those<space/><link><target>uncircumcised</target></link><space/>partners may act as a<space/><link><target>Natural reservoir</target><part>reservoir</part></link><space/>increasing the likelihood of acquiring an infection after sexual intercourse. Another mode of transmission of BV associated microbiota is to a female sexual partner via the skin-to-skin transfer. BV may be transmitted via the perineal enteric bacteria from the microbiota of the female and male genitalia.<extension extension_name='ref' name="Amaya2015"></extension></paragraph><heading level='2'>Diagnosis</heading><paragraph><link><target>File:Bacterial vaginosis workup.jpg</target><part>thumb</part><part>A<space/><link><target>pH indicator</target></link><space/>to detect vaginal alkalinization (here showing approximately pH 8), and a<space/><link><target>microscope slide</target></link><space/>to microscopically detect<space/><link><target>clue cells</target></link>.</part></link>To make a diagnosis of bacterial vaginosis, a swab from inside the vagina should be obtained. These swabs should be tested for:</paragraph><list type='bullet'><listitem>A characteristic &quot;fishy&quot; odor on<space/><link><target>Wet mount#Wet mount or temporary mount</target><part>wet mount</part></link>. This test, called the<space/><italics>whiff test</italics>, is performed by adding a small amount of<space/><link><target>potassium hydroxide</target></link><space/>to a<space/><link><target>microscopic slide</target></link><space/>containing the vaginal discharge. A characteristic<space/><link><target>fishy odor</target></link><space/>is considered a positive whiff test and is suggestive of bacterial vaginosis.</listitem><listitem>Loss of<space/><link><target>acidity</target></link>. To control bacterial growth, the vagina is normally slightly acidic with a<space/><link><target>pH</target></link><space/>of 3.84.2. A swab of the discharge is put onto<space/><link><target>litmus paper</target></link><space/>to check its acidity. A pH greater than 4.5 is considered alkaline and is suggestive of bacterial vaginosis.</listitem><listitem>The presence of<space/><italics><link><target>clue cell</target><trail>s</trail></link></italics><space/>on wet mount. Similar to the whiff test, the test for clue cells is performed by placing a drop of<space/><link><target>sodium chloride</target></link><space/>solution on a slide containing vaginal discharge. If present, clue cells can be visualized under a microscope. They are so-named because they give a clue to the reason behind the discharge. These are<space/><link><target>epithelial</target></link><space/>cells that are coated with bacteria.</listitem></list><paragraph>Two positive results in addition to the discharge itself are enough to diagnose BV. If there is no discharge, then all three criteria are needed.<extension extension_name='ref' name="Amsel"><template><target>cite journal</target><arg name="author"><space/>Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK<space/></arg><arg name="title"><space/>Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations<space/></arg><arg name="journal"><space/>Am. J. Med.<space/></arg><arg name="volume"><space/>74<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>14–22<space/></arg><arg name="year"><space/>1983<space/></arg><arg name="pmid"><space/>6600371<space/></arg><arg name="doi"><space/>10.1016/0002-9343(83)91112-9<space/></arg></template></extension><template><target>primary-source inline</target><arg name="date">December 2011</arg></template>Differential diagnosis for bacterial vaginosis includes the following:<extension extension_name='ref' name="diagnosis"><template><target>cite web</target><arg name="title">Diseases Characterized by Vaginal Discharge</arg><arg name="url">http://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm</arg><arg name="website">cdc.gov</arg><arg name="publisher">Centers for Disease Control and Prevention</arg></template></extension></paragraph><list type='bullet'><listitem><link><target>Vaginal discharge</target><part>Normal vaginal discharge</part></link>.</listitem><listitem><link><target>Candidiasis</target></link><space/>(thrush, or a yeast infection).</listitem><listitem><link><target>Trichomoniasis</target></link>, an infection caused by<space/><italics><link><target>Trichomonas vaginalis</target></link></italics>.</listitem></list><paragraph>The Center For Disease Control (CDC) defines STIs as &quot;a variety of clinical syndromes and infections caused by pathogens that can be acquired and transmitted through sexual activity.&quot;<extension extension_name='ref'>Workowski, Kimberly A. and Bolan, Gail A. Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recomm Rep 2015; volume 64, issue 3:p.1.</extension><space/>But the CDC does not specifically identify BV as sexually transmitted infection.<extension extension_name='ref' name="cdc.gov"></extension></paragraph><heading level='3'>Amsel criteria</heading><paragraph>In clinical practice BV can be diagnosed using the Amsel criteria:<extension extension_name='ref' name="Amsel"></extension></paragraph><list type='numbered'><listitem>Thin, white, yellow, homogeneous discharge</listitem><listitem><link><target>Clue cell</target><trail>s</trail></link><space/>on<space/><link><target>microscopy</target></link></listitem><listitem><link><target>pH</target></link><space/>of vaginal fluid &gt;4.5</listitem><listitem>Release of a fishy odor on adding<space/><link><target>alkali</target></link>10%<space/><link><target>potassium hydroxide</target></link><space/>(KOH) solution.</listitem></list><paragraph>At least three of the four criteria should be present for a confirmed diagnosis.<extension extension_name='ref' name="GCH"><template><target>cite web</target><arg name="url">http://www.guideline.gov/summary/summary.aspx?doc_id</arg><arg name="title">National guideline for the management of bacterial vaginosis (2006)<space/></arg><arg name="work">Clinical Effectiveness Group, British Association for Sexual Health and HIV (BASHH)<space/></arg></template></extension>A modification of the Amsel criteria accepts the presence of two instead of three factors, and is considered equally diagnostic.</paragraph><heading level='3'>Gram stain</heading><paragraph>An alternative is to use a Gram-stained vaginal smear, with the Hay/Ison<extension extension_name='ref' name="HayIson"><template><target>cite journal</target><arg name="author"><space/>Ison CA, Hay PE<space/></arg><arg name="title"><space/>Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics<space/></arg><arg name="journal"><space/>Sex Transm Infect<space/></arg><arg name="volume"><space/>78<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>413–5<space/></arg><arg name="year"><space/>2002<space/></arg><arg name="pmid"><space/>12473800<space/></arg><arg name="pmc"><space/>1758337<space/></arg><arg name="doi"><space/>10.1136/sti.78.6.413<space/></arg></template></extension><space/>criteria or the Nugent<extension extension_name='ref' name="Nugent1991"><template><target>cite journal</target><arg name="author"><space/>Nugent RP, Krohn MA, Hillier SL<space/></arg><arg name="title"><space/>Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation<space/></arg><arg name="journal"><space/>J. Clin. Microbiol.<space/></arg><arg name="volume"><space/>29<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>297–301<space/></arg><arg name="year"><space/>1991<space/></arg><arg name="pmid"><space/>1706728<space/></arg><arg name="pmc"><space/>269757<space/></arg><arg name="url"><space/>http://jcm.asm.org/cgi/pmidlookup?view</arg></template></extension><space/>criteria. The Hay/Ison criteria are defined as follows:<extension extension_name='ref' name="GCH"></extension></paragraph><list type='bullet'><listitem>Grade 1 (Normal):<space/><link><target>Lactobacillus</target></link><space/>morphotypes predominate.</listitem><listitem>Grade 2 (Intermediate): Mixed flora with some Lactobacilli present, but Gardnerella or Mobiluncus morphotypes also present.</listitem><listitem>Grade 3 (Bacterial Vaginosis): Predominantly Gardnerella and/or Mobiluncus morphotypes. Few or absent Lactobacilli. (Hay et al., 1994)</listitem></list><paragraph>Gardnerella vaginalis is the main culprit in BV. Gardnerella vaginalis is a short rod (coccobacillus). Hence, the presence of clue cells and gram variable coccobacilli are indicative or diagnostic of bacterial vaginosis.</paragraph><paragraph>The standards for research are the Nugent criteria.<extension extension_name='ref' name="Nugent1991"></extension><space/>In this scale, a score of 0-10 is generated from combining three other scores. This method is time consuming and requires trained staff, but it has high<space/><link><target>Inter-observer reliability</target><part>interobserver reliability</part></link>.<template><target>Citation needed</target><arg name="date">May 2010</arg></template><space/>The scores are as follows:</paragraph><list type='bullet'><listitem>03 is considered negative for BV</listitem><listitem>46 is considered intermediate</listitem><listitem>7+ is considered indicative of BV.</listitem></list><paragraph>At least 1020 high power (1000 oil immersion) fields are counted and an average determined.</paragraph><table class="wikitable"><tablerow><tablecell>Lactobacillus morphotypes average per high powered (1000 oil immersion) field. View multiple fields.</tablecell><tablecell><paragraph>|<link><target>Gardnerella</target></link><space/>/<space/><link><target>Bacteroides</target></link><space/>morphotypes average per high powered (1000 oil immersion) field. View multiple fields.</paragraph><preblock><preline><space/>||</preline></preblock><paragraph>Curved Gram variable rods average per high powered (1000 oil immersion) field. View multiple fields (note that this factor is less important scores of only 02 are possible)</paragraph></tablecell></tablerow><tablerow><tablecell><list type='bullet'><listitem>Score 0 for &gt;30</listitem><listitem>Score 1 for 1530</listitem><listitem>Score 2 for 14</listitem><listitem>Score 3 for &lt;1 (this is an average, so results can be &gt;0, yet &lt;1)</listitem><listitem>Score 4 for 0</listitem></list></tablecell><tablecell><paragraph>|</paragraph><list type='bullet'><listitem>Score 0 for 0</listitem><listitem>Score 1 for &lt;1 (this is an average, so results can be &gt;0, yet &lt;1)</listitem><listitem>Score 2 for 14</listitem><listitem>Score 3 for 530</listitem><listitem>Score 4 for &gt;30</listitem></list></tablecell><tablecell><paragraph>|</paragraph><list type='bullet'><listitem>Score 0 for 0</listitem><listitem>Score 1 for &lt;5</listitem><listitem>Score 2 for 5+</listitem></list></tablecell></tablerow></table><paragraph><link><target>DNA hybridization</target></link><space/>testing with Affirm VPIII was compared to the Gram stain using the Nugent criteria.<extension extension_name='ref' name="pmid17078859"><template><target>cite journal</target><arg name="author"><space/>Gazi H, Degerli K, Kurt O, Teker A, Uyar Y, Caglar H, Kurutepe S, Surucuoglu S<space/></arg><arg name="title"><space/>Use of DNA hybridization test for diagnosing bacterial vaginosis in women with symptoms suggestive of infection<space/></arg><arg name="journal"><space/>APMIS<space/></arg><arg name="volume"><space/>114<space/></arg><arg name="issue"><space/>11<space/></arg><arg name="pages"><space/>784–7<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>17078859<space/></arg><arg name="doi"><space/>10.1111/j.1600-0463.2006.apm_485.x<space/></arg><arg name="last8"><space/>Surucuoglu<space/></arg></template></extension><space/>The Affirm VPIII test may be used for the rapid diagnosis of BV in symptomatic women but uses expensive proprietary equipment to read results, and does not detect other pathogens that cause BV, including Prevotella spp, Bacteroides spp, &amp; Mobiluncus spp.</paragraph><heading level='2'>Prevention</heading><paragraph>Some steps suggested to lower the risk include: not<space/><link><target>douching</target></link>, avoiding sex, or limiting the number of sex partners.<extension extension_name='ref' name="CDCbv2014"><template><target>cite web</target><arg name="url">http://www.cdc.gov/std/bv/stdfact-bacterial-vaginosis.htm<space/></arg><arg name="title">Bacterial Vaginosis – CDC Fact Sheet<space/></arg><arg name="author"><space/></arg><arg name="date">March 11, 2014<space/></arg><arg name="publisher">[[Centers for Disease Control and Prevention]]<space/></arg><arg name="accessdate">6 May 2015</arg></template></extension></paragraph><paragraph>One review concluded that probiotics may help prevent re-occurrence.<extension extension_name='ref' name="Don2014"></extension><space/>Another review found that while there is tentative evidence it is not strong enough to recommend their use for this purpose.<extension extension_name='ref' name="Mastro2013"><template><target>cite journal</target><arg name="last1">Mastromarino</arg><arg name="first1">Paola</arg><arg name="last2">Vitali</arg><arg name="first2">Beatrice</arg><arg name="last3">Mosca</arg><arg name="first3">Luciana</arg><arg name="title">Bacterial vaginosis: a review on clinical trials with probiotics</arg><arg name="url">http://www.newmicrobiologica.org/PUB/allegati_pdf/2013/3/229.pdf</arg><arg name="journal">New Microbiologica</arg><arg name="date">2013</arg><arg name="volume">36</arg><arg name="pages">229–238</arg><arg name="pmid">23912864</arg></template></extension></paragraph><paragraph>Antibiotic treatment of male partners could re-establish the normal microbiota of the male uro-genital tract. BV associated bacteria in or on the male genitals may promote relapse, reinfection of, women with BV. Treating the male partner is an effective and safe intervention and offers the advantage of preventing the recurrence of infection.<extension extension_name='ref' name="Amaya2015"><template><target>cite journal</target><arg name="last1">Amaya-Guio</arg><arg name="first1">Jairo</arg><arg name="last2">Martinez-Velasquez</arg><arg name="first2">Mercy Yolima</arg><arg name="last3">Viveros-Carreño</arg><arg name="first3">David Andres</arg><arg name="last4">Sierra-Barrios</arg><arg name="first4">Eloisa Mercedes</arg><arg name="last5">Grillo-Ardila</arg><arg name="first5">Carlos F</arg><arg name="last6">Amaya-Guio</arg><arg name="first6">Jairo</arg><arg name="title">Antibiotic treatment for the sexual partners of women with bacterial vaginosis</arg><arg name="year">2015</arg><arg name="doi">10.1002/14651858.CD011701</arg></template></extension></paragraph><heading level='2'>Treatment</heading><heading level='3'>Antibiotics</heading><paragraph>Treatment is typically with the<space/><link><target>antibiotic</target><trail>s</trail></link><space/><link><target>metronidazole</target></link><space/>or<space/><link><target>clindamycin</target></link>.<extension extension_name='ref' name="Od2009"></extension><space/>They can be either given by mouth or applied inside the vagina.<extension extension_name='ref' name="Od2009"><template><target>cite journal</target><arg name="author"><space/>Oduyebo OO, Anorlu RI, Ogunsola FT<space/></arg><arg name="title"><space/>The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women<space/></arg><arg name="journal"><space/>Cochrane Database Syst Rev<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>CD006055<space/></arg><arg name="year"><space/>2009<space/></arg><arg name="pmid"><space/>19588379<space/></arg><arg name="doi"><space/>10.1002/14651858.CD006055.pub2<space/></arg><arg name="editor1-last"><space/>Oduyebo<space/></arg><arg name="editor1-first"><space/>Oyinlola O<space/></arg></template></extension><space/>About 10% to 15% of people; however, do not improve with the first course of antibiotics and recurrence rates of up to 80% have been documented.<extension extension_name='ref' name="SenokVerstraelen2009"><template><target>cite journal</target><arg name="last1">Senok</arg><arg name="first1">Abiola C</arg><arg name="last2">Verstraelen</arg><arg name="first2">Hans</arg><arg name="last3">Temmerman</arg><arg name="first3">Marleen</arg><arg name="last4">Botta</arg><arg name="first4">Giuseppe A</arg><arg name="last5">Senok</arg><arg name="first5">Abiola C</arg><arg name="title">Probiotics for the treatment of bacterial vaginosis</arg><arg name="year">2009</arg><arg name="doi">10.1002/14651858.CD006289.pub2</arg><arg name="pmid">19821358</arg></template></extension><space/>Recurrence rates are increased with sexual activity with the same pre-/posttreatment partner and inconsistent condom use although estrogen-containing contraceptives decrease recurrence.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM, De Guingand D, Morton AN, Fairley CK<space/></arg><arg name="title"><space/>Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.<space/></arg><arg name="journal"><space/>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America<space/></arg><arg name="volume"><space/>56<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>777–86<space/></arg><arg name="date"><space/>Mar 2013<space/></arg><arg name="pmid"><space/>23243173<space/></arg><arg name="doi"><space/>10.1093/cid/cis1030<space/></arg></template></extension><space/>When clindamycin is given to pregnant women symptomatic with BV before 22 weeks of gestation the risk of pre-term birth before 37 weeks of gestation is lower.<extension extension_name='ref' name="LamontNhan-Chang"><template><target>cite journal</target><arg name="last1">Lamont</arg><arg name="first1">Ronald F.</arg><arg name="last2">Nhan-Chang</arg><arg name="first2">Chia-Ling</arg><arg name="last3">Sobel</arg><arg name="first3">Jack D.</arg><arg name="last4">Workowski</arg><arg name="first4">Kimberly</arg><arg name="last5">Conde-Agudelo</arg><arg name="first5">Agustin</arg><arg name="last6">Romero</arg><arg name="first6">Roberto</arg><arg name="title">Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis</arg><arg name="journal">American Journal of Obstetrics and Gynecology</arg><arg name="volume">205</arg><arg name="issue">3</arg><arg name="year">2011</arg><arg name="pages">177–190</arg><arg name="issn">00029378</arg><arg name="doi">10.1016/j.ajog.2011.03.047</arg><arg name="pmid">22071048</arg></template></extension></paragraph><paragraph>Other antibiotics that may work include macrolides, lincosamides, nitroimidazoles, and penicillins.<extension extension_name='ref' name="Amaya2015"></extension></paragraph><paragraph>Bacterial vaginosis is not considered a<space/><link><target>sexually transmitted infection</target></link>, and treatment of a male sexual partner of a woman with bacterial vaginosis is not recommended.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Mehta SD<space/></arg><arg name="title"><space/>Systematic review of randomized trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women<space/></arg><arg name="journal"><space/>Sex Transm Dis<space/></arg><arg name="volume"><space/>39<space/></arg><arg name="issue"><space/>10<space/></arg><arg name="pages"><space/>822–30<space/></arg><arg name="date"><space/>October 2012<space/></arg><arg name="pmid"><space/>23007709<space/></arg><arg name="doi"><space/>10.1097/OLQ.0b013e3182631d89<space/></arg></template></extension><extension extension_name='ref' name="pmid10818662"><template><target>cite journal</target><arg name="author"><space/>Potter J<space/></arg><arg name="title"><space/>Should sexual partners of women with bacterial vaginosis receive treatment?<space/></arg><arg name="journal"><space/>Br J Gen Pract<space/></arg><arg name="volume"><space/>49<space/></arg><arg name="issue"><space/>448<space/></arg><arg name="pages"><space/>913–8<space/></arg><arg name="date"><space/>November 1999<space/></arg><arg name="pmid"><space/>10818662<space/></arg><arg name="pmc"><space/>1313567<space/></arg><arg name="url"><space/>http://openurl.ingenta.com/content/nlm?genre</arg></template></extension></paragraph><heading level='3'>Probiotics</heading><paragraph>A 2009 Cochrane review found tentative but insufficient evidence for probiotics as a treatment for BV.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Senok</arg><arg name="first1">AC</arg><arg name="last2">Verstraelen</arg><arg name="first2">H</arg><arg name="last3">Temmerman</arg><arg name="first3">M</arg><arg name="last4">Botta</arg><arg name="first4">GA</arg><arg name="title">Probiotics for the treatment of bacterial vaginosis.</arg><arg name="journal">The Cochrane database of systematic reviews</arg><arg name="date">7 October 2009</arg><arg name="issue">4</arg><arg name="pages">CD006289</arg><arg name="pmid">19821358</arg></template></extension><space/>A 2014 review reached the same conclusion.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Huang</arg><arg name="first1">H</arg><arg name="last2">Song</arg><arg name="first2">L</arg><arg name="last3">Zhao</arg><arg name="first3">W</arg><arg name="title">Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials.</arg><arg name="journal">Archives of gynecology and obstetrics</arg><arg name="date">June 2014</arg><arg name="volume">289</arg><arg name="issue">6</arg><arg name="pages">1225–34</arg><arg name="pmid">24318276</arg></template></extension><space/>A 2013 review found some evidence supporting the use of probiotics during pregnancy.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">VandeVusse</arg><arg name="first1">L</arg><arg name="last2">Hanson</arg><arg name="first2">L</arg><arg name="last3">Safdar</arg><arg name="first3">N</arg><arg name="title">Perinatal outcomes of prenatal probiotic and prebiotic administration: an integrative review.</arg><arg name="journal">The Journal of perinatal & neonatal nursing</arg><arg name="date">2013</arg><arg name="volume">27</arg><arg name="issue">4</arg><arg name="pages">288–301; quiz E1-2</arg><arg name="pmid">24164813</arg></template></extension></paragraph><heading level='2'>Complications</heading><paragraph>Although previously considered a mere nuisance infection, untreated bacterial vaginosis may cause complications, such as increased susceptibility to sexually transmitted infections including HIV and<space/><link><target>pregnancy complication</target><trail>s</trail></link>.<extension extension_name='ref' name="Amaya2015"></extension><extension extension_name='ref' name="CDC"><template><target>cite web</target><arg name="url">http://www.cdc.gov/std/bv/STDFact-Bacterial-Vaginosis.htm#Complications<space/></arg><arg name="title">STD Facts — Bacterial Vaginosis (BV)<space/></arg><arg name="accessdate">4 December 2007<space/></arg><arg name="work">CDC</arg><arg name="archiveurl"><space/>https://web.archive.org/web/20071203214825/http://www.cdc.gov/std/bv/STDFact-Bacterial-Vaginosis.htm</arg><arg name="archivedate"><space/>3 December 2007<space/></arg><arg name="deadurl"><space/>no</arg></template></extension></paragraph><paragraph>It has been shown that HIV-infected women with bacterial vaginosis (BV) have higher HIV concentrations in their vaginal secretions.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/></arg><arg name="date"><space/>Jul 2005<space/></arg><arg name="title"><space/></arg><arg name="url"><space/></arg><arg name="journal"><space/>J Acquir Immune Defic Syndr<space/></arg><arg name="volume"><space/>39<space/></arg><arg name="issue"><space/>3</arg><arg name="pages"><space/>340–6<space/></arg></template></extension><space/>Diagnostic criteria for BV have also been associated with a female genital tract factor that induces expression of HIV.<extension extension_name='ref' name="Amaya2015"></extension><space/>The elevated HIV copy number in vaginal secretions of women with BV has been associated with an increased risk of heterosexual transmission of HIV.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/></arg><arg name="year"><space/>2012<space/></arg><arg name="title"><space/></arg><arg name="url"><space/></arg><arg name="journal"><space/>PLoS Med<space/></arg><arg name="volume"><space/>9<space/></arg><arg name="issue"><space/>6</arg><arg name="page"><space/>e1001251<space/></arg><arg name="doi"><space/>10.1371/journal.pmed.1001251<space/></arg></template></extension></paragraph><paragraph>There is evidence of an association between BV and increased rates of sexually transmitted infections such as HIV/AIDS.<extension extension_name='ref' name="Amaya2015"></extension><space/>BV is associated with up to a six-fold increase of HIV shedding. There is also a correlation between the absence of vaginal lactobacilli and infection of Neisseria gonorrhoeae and<space/><link><target>Chlamydia trachomatis</target></link>. BV is a risk factor for viral shedding and herpes virus type 2 infection. BV may increase the risk infection or reactivation of HPV.<extension extension_name='ref' name="Amaya2015"></extension><extension extension_name='ref' name="SenokVerstraelen2009"></extension></paragraph><paragraph>In addition, bacterial vaginosis an<space/><link><target>intercurrent disease in pregnancy</target></link><space/>may increase the risk of<space/><link><target>pregnancy complications</target></link>, most notably<space/><link><target>premature birth</target></link><space/>or<space/><link><target>miscarriage</target></link>.<extension extension_name='ref'><link type='external' href='http://www.nhs.uk/conditions/bacterialvaginosis/Pages/Introduction.aspx'>Bacterial vaginosis</link><space/>from<space/><link><target>National Health Service</target></link>, UK. Page last reviewed: 03/10/2013</extension><space/>Pregnant women with BV have a higher risk of chorioamnionitis, miscarriage, preterm birth, premature rupture of membranes, and postpartum endometritis. BV is associated with gynaecological and obstetric complications. Data suggest an association between BV, tubal factor infertility, and pelvic inflammatory disease. Women with BV who are treated with vitro fertilization have a lower implantation rate and higher rates of early pregnancy loss.<extension extension_name='ref' name="Amaya2015"></extension><extension extension_name='ref' name="SenokVerstraelen2009"></extension></paragraph><heading level='2'>Epidemiology</heading><paragraph>BV is the most common infection of the vagina in women of reproductive age.<extension extension_name='ref' name="NIH2013O"></extension><space/>The percentage of women affected at any given time vary between 5% and 70%.<extension extension_name='ref' name="Ken2013"></extension><space/>BV is most common in parts of Africa and least common in Asia and Europe.<extension extension_name='ref' name="Ken2013"></extension><space/>In the United States about 30% of those between the ages of 14 and 49 are affected.<extension extension_name='ref' name="CDC2010Stats"></extension><space/>Rates vary considerably between ethnic groups within a country.<extension extension_name='ref' name="Ken2013"></extension></paragraph><heading level='2'>References</heading><paragraph><template><target>reflist</target><arg>32em</arg></template></paragraph><heading level='2'>External links</heading><paragraph><template><target>Diseases of the pelvis and genitals</target><arg name="state">collapsed</arg></template></paragraph><paragraph><template><target>DEFAULTSORT:Bacterial Vaginosis</target></template><link><target>Category:Bacterial vaginosis</target><part></part></link><link><target>Category:Sexually transmitted diseases and infections</target></link><link><target>Category:Inflammatory diseases of female pelvic organs</target></link><link><target>Category:Vagina</target></link><link><target>Category:RTT</target></link></paragraph></article>